周期第2天血清胰岛素样生长因子-1水平作为预测低反应者控制性卵巢过度刺激结局的预后工具
该回顾性队列研究纳入2013至2015年在本机构接受体外受精治疗、未行雌激素预处理的21至42岁女性184例,比较低反应者与年龄匹配的正常及高反应者的周期第2天血清IGF-1水平,并分析低反应者雌激素预处理前后变化。低反应者周期第2天IGF-1水平显著高于正常和高反应者,IGF-1>72 ng/mL可预测不良周期结局;黄体期雌激素预处理与IGF-1降低、获卵及胚胎增多、累积宫内妊娠率升高相关。
要点
- 低反应者周期第2天血清IGF-1水平较正常反应者升高逾两倍,较高反应者升高三倍。
- 低反应者周期第2天IGF-1>72 ng/mL预测不良控制性卵巢过度刺激结局的敏感度70%、特异度78%,曲线下面积0.83。
- 低反应者黄体期雌激素预处理与IGF-1水平显著降低、获卵及双原核胚胎增多、累积宫内妊娠率升高相关。
核心结论
- 尽管周期第2天卵泡刺激素水平正常,对控制性卵巢刺激反应不良的患者周期第2天血清IGF-1水平显著高于年龄匹配的正常和高反应者。
- 低反应者周期第2天IGF-1>72 ng/mL可预测不良周期结局。
- 低反应者黄体期雌激素预处理与IGF-1水平显著降低、对刺激的反应改善、累积宫内妊娠率升高及不良妊娠结局率降低相关。
研究设计与样本
- 回顾性队列研究,基于大学附属机构,纳入2013至2015年在本机构接受体外受精治疗周期且未行雌激素预处理的21至42岁女性。
- 共184例患者符合纳入标准,分为低反应者(获卵≤4枚/周期取消)、正常反应者(获卵8至12枚)和高反应者(获卵≥18枚)。
- 亚分析聚焦于低反应者紧邻未预处理索引周期的下一周期,该周期实施了雌激素预处理。
主要发现
- 低反应者周期第2天血清IGF-1水平较正常反应者升高逾两倍,较高反应者升高三倍。
- 低反应者周期第2天IGF-1>72 ng/mL预测不良控制性卵巢过度刺激周期结局的敏感度70%、特异度78%,曲线下面积0.83。
- 低反应者组黄体期雌激素预处理与IGF-1水平显著降低相关。
- 与相邻未预处理索引周期相比,预处理后的低反应者组获卵数、成熟卵母细胞数及双原核胚胎数均显著增多。
- 预处理后累积宫内妊娠率更高,不良妊娠结局率更低。
关键数值与推荐
- 低反应者周期第2天IGF-1>72 ng/mL预测不良周期结局的敏感度70%、特异度78%,曲线下面积0.83。
- 低反应者定义为获卵≤4枚/周期取消,正常反应者为获卵8至12枚,高反应者为获卵≥18枚。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To study whether patients exhibiting poor ovarian response have abnormal levels of serum insulin-like growth factor (IGF)-1 on cycle day 2 when compared with age-matched normal and high responders. DESIGN: Retrospective cohort. SETTING: University-based practice. PATIENT(S): All women between the ages of 21 and 42 years who underwent in vitro fertilization treatment cycle without estrogen pretreatment at our institution between 2013 and 2015. INTERVENTION(S): Patients were separated into three groups: poor responders (≤4 oocytes retrieved/cycle cancellation), normal responders (8-12 oocytes), and high responders (≥18 oocytes). Subanalysis focused on the next cycle for poor responders adjacent to the nonpretreated index cycle, in which estrogen pretreatment was implemented. MAIN OUTCOME MEASURE(S): Serum cycle day 2: IGF-1, insulin-like growth factor-binding protein (IGFBP)-3 levels, and IGF-1:IGFBP3 ratio, number of eggs retrieved, number of two pronuclei embryos, cumulative pregnancy rate, and live birth. RESULT(S): A total of 184 patients met the inclusion criteria. The poor responder group exhibited a more than twofold increase in the cycle day IGF-1 serum levels when compared with normal responders and a threefold increase when compared with the high responders. Cycle day 2 IGF-1 level >72 ng/mL in poor responders had 70% sensitivity and 78% specificity for a negative controlled ovarian hyperstimulation cycle outcome with an area under the curve of 0.83. Luteal estrogen pretreatment in the poor responder group was associated with a significant reduction in IGF-1 levels. Significantly, more retrieved and mature oocytes, as well as two pronuclei embryos, were achieved in the pretreated poor responder group when compared with the yield from their adjacent nonpretreated index cycles. Furthermore, cumulative rates were higher for intrauterine pregnancies, and lower for negative pregnancy outcome. CONCLUSION(S): Patients who respond poorly to controlled ovarian stimulation, despite normal cycle day 2 follicle-stimulating hormone levels, have significantly higher serum cycle day 2 IGF-1 levels when compared with age-matched normal and high responders. Cycle day 2 IGF-1 level >72 ng/mL in poor responders was predictive of a negative cycle outcome. Luteal estrogen pretreatment in the poor responder group was associated with a significant reduction in IGF-1 levels, improved response to stimulation, and higher cumulative rates for intrauterine pregnancies, and lower for negative pregnancy outcome.
引用
- Man L, Lekovich J, Canon C, et al. Cycle day 2 insulin-like growth factor-1 serum levels as a prognostic tool to predict controlled ovarian hyperstimulation outcomes in poor responders. Fertil Steril. 2020. PMID: 32482254. doi:10.1016/j.fertnstert.2020.02.111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。